Cargando…
Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 Spike
The interaction of the SARS-CoV-2 Spike receptor binding domain (RBD) with the ACE2 receptor on host cells is essential for viral entry. RBD is the dominant target for neutralizing antibodies and several neutralizing epitopes on RBD have been molecularly characterized. Analysis of circulating SARS-C...
Autores principales: | Graham, Carl, Seow, Jeffrey, Huettner, Isabella, Khan, Hataf, Kouphou, Neophytos, Acors, Sam, Winstone, Helena, Pickering, Suzanne, Galao, Rui Pedro, Lista, Maria Jose, Jimenez-Guardeno, Jose M, Laing, Adam G., Wu, Yin, Joseph, Magdalene, Muir, Luke, Ng, Weng M., Duyvesteyn, Helen M. E., Zhao, Yuguang, Bowden, Thomas A., Shankar-Hari, Manu, Rosa, Annachiara, Cherepanov, Peter, McCoy, Laura E., Hayday, Adrian C., Neil, Stuart J.D., Malim, Michael H., Doores, Katie J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872354/ https://www.ncbi.nlm.nih.gov/pubmed/33564766 http://dx.doi.org/10.1101/2021.02.03.429355 |
Ejemplares similares
-
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant
por: Graham, Carl, et al.
Publicado: (2021) -
Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infections
por: Dupont, Liane, et al.
Publicado: (2021) -
A neutralizing epitope on the SD1 domain of SARS-CoV-2 spike targeted following infection and vaccination
por: Seow, Jeffrey, et al.
Publicado: (2022) -
Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern
por: Dupont, Liane, et al.
Publicado: (2021) -
TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction
por: Khan, Hataf, et al.
Publicado: (2021)